Last reviewed · How we verify

NCT06123715: PROVISION

Perioperative Vitamin C to Reduce Persistent Pain After Total Knee Arthroplasty

Recruiting now Phase 2 Last updated 25 April 2025
What this trial tests

Phase 2 trial testing Vitamin C in Chronic Pain in 300 participants. Currently enrolling.

Timeline
16 April 2024
Primary endpoint
31 December 2025
31 December 2026

Quick facts

Lead sponsorUniversity Health Network, Toronto
PhasePhase 2
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment300
Start date16 April 2024
Primary completion31 December 2025
Estimated completion31 December 2026
Sites3 locations across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University Health Network, Toronto

Who can join

18 and older, any sex, with Chronic Pain or Knee Pain Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Phase II Multicentre, pilot, parallel-group, blinded, 1:1 randomized controlled trial to determine the feasibility of conducting a larger definitive trail of using vitamin C to reduce persistent pain in patients undergoing total knee arthroplasty surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vitamin C

Trials testing the same drug.

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other University Health Network, Toronto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06123715.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing